Effect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer Diagnosis
- 1 December 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 138 (12), 1323-1328
- https://doi.org/10.1001/archsurg.138.12.1323
Abstract
Research from JAMA Surgery — Effect of Genetic Cancer Risk Assessment on Surgical Decisions at Breast Cancer DiagnosisKeywords
This publication has 22 references indexed in Scilit:
- The Local Therapy for Breast Cancer as a Model for Evidence-Based Medical CareThe Cancer Journal, 2002
- BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility GenesJournal of Clinical Oncology, 2002
- Factors Predicting the Use of Breast-Conserving Therapy in Stage I and II Breast CarcinomaJournal of Clinical Oncology, 2001
- Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 TrialJNCI Journal of the National Cancer Institute, 2000
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2American Journal of Human Genetics, 1998
- BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast CancerNew England Journal of Medicine, 1997
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast CancerNew England Journal of Medicine, 1995
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989